Nuveen Asset Management’s Axsome Therapeutics AXSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
$18.7M Buy
221,202
+119,780
+118% +$10.1M 0.01% 1228
2024
Q3
$9.11M Sell
101,422
-1,223
-1% -$110K ﹤0.01% 1664
2024
Q2
$8.26M Sell
102,645
-142,882
-58% -$11.5M ﹤0.01% 1699
2024
Q1
$19.6M Buy
245,527
+10,881
+5% +$868K 0.01% 1195
2023
Q4
$18.7M Buy
234,646
+18,089
+8% +$1.44M 0.01% 1206
2023
Q3
$15.1M Buy
216,557
+115,342
+114% +$8.06M 0.01% 1217
2023
Q2
$7.27M Sell
101,215
-13,307
-12% -$956K ﹤0.01% 1687
2023
Q1
$7.06M Sell
114,522
-7,423
-6% -$458K ﹤0.01% 1692
2022
Q4
$9.41M Sell
121,945
-571,579
-82% -$44.1M ﹤0.01% 1535
2022
Q3
$30.9M Sell
693,524
-77,473
-10% -$3.46M 0.01% 746
2022
Q2
$29.5M Buy
770,997
+348,317
+82% +$13.3M 0.01% 792
2022
Q1
$14.1M Sell
422,680
-71,526
-14% -$2.38M ﹤0.01% 1418
2021
Q4
$18.7M Buy
494,206
+2,949
+0.6% +$111K 0.01% 1271
2021
Q3
$14.6M Sell
491,257
-167,077
-25% -$4.97M ﹤0.01% 1498
2021
Q2
$44.4M Buy
658,334
+159,584
+32% +$10.8M 0.01% 814
2021
Q1
$28.2M Sell
498,750
-8,433
-2% -$477K 0.01% 1065
2020
Q4
$41.3M Sell
507,183
-24,372
-5% -$1.99M 0.01% 805
2020
Q3
$37.9M Buy
531,555
+314,466
+145% +$22.4M 0.01% 692
2020
Q2
$17.9M Buy
217,089
+35,913
+20% +$2.96M 0.01% 1119
2020
Q1
$10.7M Buy
181,176
+80,000
+79% +$4.71M 0.01% 1254
2019
Q4
$10.5M Sell
101,176
-2,383
-2% -$246K ﹤0.01% 1566
2019
Q3
$2.1M Buy
103,559
+5,837
+6% +$118K ﹤0.01% 2372
2019
Q2
$2.52M Buy
+97,722
New +$2.52M ﹤0.01% 2322